Centipede venom trumps morphine in mouse study of pain

Centipede picturePlacing a Chinese red headed centipede on a burn can speed up the healing process, according to ancient Chinese medicine. But a mouse study published today suggests that what the Chinese interpreted as a healing effect may in fact have been the handiwork of a pain-inhibiting peptide contained within this centipede’s venom, which kills insects but is harmless in humans. The results indicate that the peptide, called m-SLPTX-Ssm6a, is a powerful analgesic that, in some cases, surpasses the effect of morphine. Given its apparent lack of side effects, Ssm6a is seen by scientists as an attractive candidate drug compound that might prove suitable for treating chronic pain.

Researchers first discovered Ss6ma’s effect by screening it, and other peptides, for the ability to inhibit Nav 1.7, a channel located on the surface of nerve cells that allows sodium to transmit pain signals when the cell membrane is depolarized. Nav 1.7’s importance in pain signaling came to light in 2006 when researchers linked mutations in the channel to a rare genetic condition in which people are unable to perceive pain. The finding led many researchers to suggest developing pain medications composed of small molecules that could block the channel.

But there was a problem with this approach: Nav 1.7 is one of nine types of so-called ‘voltage-gated sodium channels’, all endowed with similar channel entrances that, if blocked all at once, would lead to major neurological malfunctions including cardiac arrest. “This makes it really hard to get selectivity,” explains Glenn King, a structural biologist of the University of Queensland, Australia, and a co-author of the study, which appears in the Proceedings of the National Academy of Sciences. Luckily, he says, “toxins found in venoms are much bigger,” so their action does not take place at the channel entrance.

Continue reading

Months after an injury has healed, receptors involved in modulating pain remain active

shutterstock_139125542Pain researchers know that, in the immediate aftermath of a severe injury, pain sensitization pathways become active, causing the body to produce opioids—naturally occurring chemicals that inhibit pain by activating receptors. But a mouse study published today in Science reveals that a specific type of opioid receptor found on the surface of nerve cells remains hyperactive months after an injury has healed—a period much longer than previously thought. Moreover, blocking this receptor from binding opioids can produce opioid withdrawal, much like that experienced by people addicted to heroin or codeine. This finding suggests that opioids only serve to mask underlying pain, shedding light on why some chronic nature of pain disorders.

To study the long-term role of ‘endogenous’ opioids produced naturally by the body, scientists created an inflammatory response in the paws of mice by injecting a dose of toxic bacteria fragments. The researchers then allowed the injury to heal for a period of three weeks or more, all the while monitoring how sensitive the area was by using molecular biomarkers and recording how often the rodents made facial grimaces or withdrew their paws when the injured area was touched.

Six months on, once the injury had healed, the researchers administered naltrexone methobromide, a drug that blocks the receptors that can normally bind to opioids. Surprisingly, blocking the receptor’s activity caused the pain to return, even though considerable time had passed. Moreover, the mice also exhibited the telltale signs of opioid withdrawal, such as jumping, shaking and teeth chattering. “We think it’s possible that the body becomes dependent on the endogenous opioid system after an injury,” says neurobiologist and co-author Bradley Taylor, of the University of Kentucky in Lexington, “but this is speculative.” If these results are further validated, this could be the first recorded expression of what the researchers call ‘endogenous opioid withdrawal’.

Continue reading